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events in patients undergoing lower extremity vein bypass surgery
C.D. Owens, P.M. Ridker, M. Belkin, A.D. Hamdan, F. Pomposelli, F. Logerfo,
M.A. Creager and M.S. Conte
Objectives. Inflammatory markers such as high-sensitivity C-reactive protein
(hsCRP) are associated with an increased risk of cardiovascular events and
with the severity of peripheral arterial disease. The effects of inflammation
on the development of vein graft disease remain speculative. We hypothe-
sized that high levels of inflammatory markers would identify patients at in-
creased risk for adverse events (graft failure, major cardiovascular events)
after lower extremity bypass surgery.
Methods. Patients (n¼ 91) scheduled to undergo lower extremity bypass using
autogenous vein were enrolled into a prospective study at two institutions.
Exclusion criteria included the presence of major infection. A baseline plasma
samplewas obtained on themorningof lower extremity bypass. Biomarkers for
inflammation includedhsCRP, fibrinogen, and serumamyloidA (SAA). Values
between patients with and without critical limb ischemia were compared. Pro-
portions of events among dichotomized populations (upper limit of normal of
each laboratory assay) were compared by log-rank test.
Results. Of the patients undergoing lower extremity bypass, 69% were men,
53% were diabetic, 81% were smokers, and their mean ankle-brachial index
was 0.51  0.19. The indication for lower extremity bypass was critical limb is-
chemia in 55%. There were no perioperative deaths and two early graft occlu-
sions. During a mean follow-up of 342 days (range, 36e694 days) there were
four deaths, 27 graft-related events, and 10 other cardiovascular events. No
relationships were found between events and demographics, comorbidities,
baseline ankle-brachial index, or statin use. High-sensitivity CRP (P ¼ .005), fi-
brinogen (P < .001), and SAA (P ¼ .0001) levels were associated with critical
limb ischemia at presentation. Among patients with an elevated hsCRP (>5
mg/L) immediately before surgery, major postoperative vascular events oc-
curred in 60%(21/35), comparedwith a 32%(18/56) rate in thosewith a baseline
CRP<5mg/L (P¼ .004, log-rank test). Onmultivariable analysis, only elevated
hsCRP correlatedwith adverse graft-related or cardiovascular events (P¼.018).
Conclusions. The inflammatory biomarkers of hsCRP, fibrinogen, and SAA
correlate with peripheral arterial disease severity at presentation in patients
undergoing lower extremity bypass. Patients with elevated hsCRP are at in-
creased risk for postoperative vascular events, most of which are related to
the vein graft. These findings suggest a potential relationship between in-
flammation and outcomes after lower extremity vein bypass surgery.
Randomized comparison of percutaneous Viabahn stent grafts vs
prosthetic femoral-popliteal bypass in the treatment of superficial
femoral arterial occlusive disease
J. Kedora, S. Hohmann, W. Garrett, C. Munschaur, B. Theune and D. Gable
Objective. This randomized prospective study was designed to compare
the effectiveness of treating superficial femoral artery occlusive disease
percutaneously with expanded polytetrafluoroethylene (ePTFE)/nitinol
self-expanding stent grafts vs surgical femoral-to-above knee (AK) popliteal
artery bypass with synthetic graft material.
Methods. From March 2004 to May 2005, 100 limbs in 86 patients with
femoral-popliteal arterial occlusive disease were identified. Patients had
symptoms ranging from claudication to rest pain, with or without tissue
loss, and were prospectively randomized for treatment into one of two
groups. The limbs were treated percutaneously with angioplasty and one
or more self-expanding stent grafts (n ¼ 50) or surgically with femoral-
to-AK popliteal artery bypass using synthetic Dacron or ePTFE grafts (n ¼
50). The mean  SD total length of artery stented was 25.6  15 cm. Fol-
low-up evaluation with ankle-brachial indices and color flow duplex sonog-
raphy imaging were performed at 3, 6, 9, and 12 months after treatment.
Results. Patients were monitored for a median of 18 months. No statistical
difference was found in the primary patency (P ¼ .895) or secondary patency
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12 months of follow-up was 84%, 82%, 75.6%, and 73.5% for the stent graft
group and 90%, 81.8%, 79.7%, and 74.2% for the femoral-popliteal surgical
group. Thirteen patients in the stent graft group had 14 reinterventions,
and 12 reinterventions occurred in the surgical group. This resulted in
secondary patency rates of 83.9% for the stent graft group and 83.7% for
the surgical group at the 12-month follow-up.
Conclusions. Management of femoral-popliteal arterial occlusive disease
using percutaneous treatment with a stent graft is comparable with surgical
revascularization with conventional femoral-to-AK popliteal artery bypass
using synthetic material up to 12 months. Longer-term follow-up would be
helpful in determining ongoing efficacy.
Popliteal artery volume flow measurement: A new and reliable predictor
of early patency after infrainguinal balloon angioplasty and subintimal
dissection
E. Ascher, A.P. Hingorani and N.A. Marks
Objective. We have investigated whether popliteal artery volume flow
(PAVF) measured immediately after balloon angioplasties of the superficial
femoral artery-popliteal segments (SFA/POP) was predictive of early (30
days) and mid-term (6 months) arterial thrombosis.
Methods. During the last 24 months, 203 patients (56% men) with a mean age
of 73  9 years had 268 duplex-guided balloon angioplasties of the SFA/POP.
Critical ischemia was the indication in 36%. Group I included 176 (66%) with
stenoses, and group II had 92 (34%) with occlusions. All patients had comple-
tion duplex examinations that included three measurements of PAVF of
below-the-knee popliteal artery.
Results. Early (30 days) thrombosis of the treated femoropopliteal arterial
segment developed in 10 patients (3.7%), three in group I (1.7%) and seven
in group II (7.6%; P < .04). All 10 cases of early thrombosis were in patients
with TransAtlantic Inter-Society Consensus (TASC) class C (6/185, 3.2%) and
D (4/26, 15%) lesions. Moreover, the 19% incidence (n ¼ 4) of early thrombo-
sis in patients with PAVF <100 mL/min (mean, 73  24 mL/min; range, 20 to
99 mL/min) was higher compared with the 2.4% rate for patients with higher
flows (mean, 176  60 mL/min; range, 100 to 450 mL/min; P < .01). At 6
months of follow-up, femoropopliteal occlusions had developed in nine
more patients, and it became apparent that low PAVF measurements were
still predictive of thrombosis (29%) when compared with higher PAVF cases
(6%; P < .002). Log-rank comparison of survival curves for cumulative pri-
mary stenosis-free patency in group I and group II demonstrated a statisti-
cally significant difference (P < .02). PAVF <100 mL/min and TASC
classification were significant predictors of early (30 days) and mid-term (6
months) arterial thrombosis after femoropopliteal angioplasties. PAVF was
the most powerful predictor of arterial thrombosis. The respective 6-month
and 12-month limb salvage rates were 98% and 94% for patients with claudi-
cation and 88% and 85% for those with limb-threatening ischemia (P < .0001).
Conclusions. Our results demonstrate that low PAVF is the most powerful
predictor of early (30 days) and mid-term (6 months) arterial thrombosis after
femoropopliteal interventions. In the presence of a low postprocedure PAVF
(<100 mL/min), one may consider not reversing the heparin or using inter-
mittent calf compression, or both, to augment the arterial flow.
Association of obesity and metabolic syndrome with the severity and
outcome of intermittent claudication
J. Golledge, A. Leicht, R.G. Crowther, P. Clancy, W.L. Spinks and F. Quigley
Background. Obesity is recognized as an independent predictor of coronary
artery disease; however, its importance in peripheral arterial disease is less
clear. The aim of this study was to assess the association between obesity
and the severity and outcome of intermittent claudication.
Methods. This studywas a prospective cohort study based at a tertiary referral
center. Sixty patients with intermittent claudication selected for conservative
treatment were assessed for obesity and metabolic syndrome by using theDecember 2006  128/130
129AbstractsInternational Diabetes Federation definition. Other risk factors, including
diabetes, hypertension, smoking history, serum lipids, adipocytokines, and
C-reactive protein, were measured by clinical and blood assessment. Obesity
and metabolic syndrome were related to the severity of peripheral arterial dis-
ease, defined by ankle-brachial pressure index and graded treadmill measured
maximumwalking distance (MWD) and initial claudication distance, by using
multiple linear regression analysis allowing for traditional atherosclerotic risk
factors. Patients were followed up for 24 months, and combined outcome was
reported in terms of death, cardiovascular events, or requirement for revascu-
larization. The effect of obesity and metabolic syndrome on outcome was
investigated by using Kaplan-Meier and Cox proportional hazard analysis.
Results. Obesity and serum adiponectin were independently associated with
the severity of peripheral arterial disease measured by ankle-brachial pres-
sure index (P ¼ .03 and .001), initial claudication distance (P ¼ .009 and
.03), and MWD (P ¼ .001 and .04). Metabolic syndrome was independently
associated only with MWD (P ¼ .02). By 24 months, outcome events occurred
in 37%  7% and 43%  9% of patients with metabolic syndrome or obesity,
respectively, compared with 0% and 11%  6% of those without these diag-
noses. Waist circumference independently predicted the likelihood of out-
come events (relative risk, 1.16; 95% confidence interval, 1.08e1.26; P < .001).
Conclusions. These findings, if confirmed in other cohorts, suggest the impor-
tance of treating obesity in patients with intermittent claudication. Serum
adiponectin concentrations may be an important guide to the efficacy of treat-
ment in patients with intermittent claudication and obesity.
Does the timing of reoperation influence the risk of graft infection?
S. Kolakowski Jr, M.J. Dougherty and K.D. Calligaro
Objective. This study compared the incidence and characteristics of graft
infection in patients who underwent early vs late revisional surgery of lower
extremity arterial bypass grafts.
Methods. Between 1992 and July 2005, 500 revisional procedures were per-
formed on 198 lower extremity bypass grafts. Patients whose revisions
were performed <30 days after the primary bypass were in the early revision
(ER) group (n ¼ 99), and those done >30 days after bypass were in the late
revision (LR) group (n ¼ 99). Infection was defined as cellulitis with graft ex-
posure or purulence in continuity with a graft that required antibiotics and
operation for infection control. Mean follow-up was 60 months (range, 2 to
60 months). Groups were compared using Student’s t test.
Results. The ER group included 66 autogenous and 33 prosthetic grafts. The LR
group consisted of 53 autogenous and 46 prosthetic grafts. Of the 500 revisional
procedures performed, 17 graft infections occurred (3.4%). Twelve (70.6%)
wereprosthetic grafts andfive (29.4%)were autogenous grafts (P¼.004).Defin-
ing the infection rate per graft rather than per revisional procedure, the ER
group had a significantly higher graft infection rate at 11% (11/99) compared
with 6.1% in the LR group (6/99; P ¼ .012). The risk of infection for prosthetic
grafts was significantly higher within the ER group at 27.3% (9/33) compared
with autogenous grafts at 3.1% (2/66; P ¼ .0001). Infection developed in three
vein grafts and three prosthetic grafts in the LR group (P¼NS). For prosthetic
graft revisions only, infection risk was 27.3% (9/33) in the ER group and 6.5%
(3/46) in the LR group (P ¼ .005). The most common cultured pathogen was
methicillin resistant Staphylococcus aureus (ER, 6/11 vs LR, 3/6; P¼NS.Within
theERgroup, theprevalence ofPseudomonas aeruginosawas significantly higher
at 27.3% (3/11) compared with 0% (0/6) in the LR group (P ¼ .04).
Conclusions. Early revision of lower extremity arterial bypass grafts has a sig-
nificantly higher risk of graft infection compared with revision>1 month after
surgery. Infectionwill develop in approximately 25% (9/33) of prosthetic grafts
that are reoperated on early. If feasible, reoperation should be delayed >1
month for prosthetic grafts needing revision. Endovascular or extra-anatomic
interventions should be considered if early revision is mandated in this group.
Magnetic resonance angiography and neuromonitoring to assess spinal
cord blood supply in thoracic and thoracoabdominal aortic aneurysm
surgery
R.J. Nijenhuis, M.J. Jacobs, G.W. Schurink, A.G.H. Kessels, J.M.A. van
Engelshoven and W.H. Backes
Objective. Preoperative knowledge of the blood-supplying trajectory to the
spinal cord is of interest, because spinal cord ischemia may occur duringthoracic aortic aneurysm (TAA) and thoracoabdominal aortic aneurysm
(TAAA) repair and possibly leads to paraplegia. The Adamkiewicz artery
(AKA) is considered to be the most important blood supplier of the thoraco-
lumbar spinal cord and has therefore been the focus in preoperative diagnos-
tic imaging. However, in TAA(A) patients, the blood supply to the spinal cord
may strongly depend on (intersegmental) collateral circulation, because
many segmental arteries are occluded as a result of atherosclerosis. Therefore,
the importance of preserving the segmental artery supplying the AKA
(SA-AKA) is debated. Here it was investigated whether (1) the AKA and
its segmental supplier can be imaged by using magnetic resonance (MR)
angiography and (2) aortic cross-clamping of the SA-AKA influences intrao-
perative spinal cord function, monitored by motor evoked potentials (MEPs).
Methods. Preoperative MR angiography was performed to localize the SA-
AKA and the AKA in 60 patients (19 TAA, 7 TAAA I, 18 TAAA II, 9 TAAA
III, and 7 TAAA IV). Spinal cord function was monitored during surgery by
using MEPs. When MEPs indicated critical ischemia, the SA-AKAwas selec-
tively reattached. To test whether aortic cross-clamping of the SA-AKA was
associated with MEP decline, the Fisher statistical exactness test was applied.
Results. The AKA and SA-AKA could be localized in all 60 (100%) patients
between vertebral levels T8 and L2 (72% left sided). In 44 (73%) patients,
the SA-AKA was cross-clamped, which led in 32% (14/44) of cases to MEP
decline. Reattachment of the preoperatively localized SA-AKA re-established
MEPs and, thus, spinal cord function in 12 of 14 cases. When the SA-AKA
was outside the area cross-clamped, the MEPs always remained stable. A sig-
nificant association (P < .01) was found between the location of the SA-AKA
relative to the aortic cross-clamps and the MEPs.
Conclusions. The AKA can be localized before surgery in 100% of TAA(A)
patients by using MR angiography. Location of the SA-AKA outside the
cross-clamped aortic area is attended with stable MEPs. Interestingly, it
was found that in most patients in whom the SA-AKA was cross-clamped,
MEPs were not affected, thus indicating sufficient collateral blood supply
to maintain spinal cord integrity. Nevertheless, preoperative knowledge of
SA-AKA location is of importance, because in 32% of patients, spinal cord
function was dependent on this supplier. Revascularization of the SA-AKA
can thereby reverse spinal cord dysfunction.
Radiation arteritis: A contraindication to carotid stenting?
C.D. Protack, A.M. Bakken, W.A. Saad, K.A. Illig, D.L. Waldman and
M.G. Davies
Background. Carotid artery stenting (CAS) for high-risk anatomic lesions is
accepted practice. Neck irradiation and radiotherapy-induced arteritis are
common indications. The clinical outcomes of CAS for radiation arteritis
have been poorly defined.
Methods. A prospective database of patients undergoing CAS at a tertiary re-
ferral academic medical center was maintained from 1999 to 2006. Patients
undergoing primary carotid artery stenting for significant atherosclerotic
(ASOD) and radiotherapy (XRT)-induced occlusive disease were analyzed.
Life-table analyses were performed to assess time-dependent outcomes.
Cox proportional hazard analysis or Fisher’s exact test was performed
to identify factors associated with outcomes. Data are presented as the
mean  SEM unless otherwise indicated.
Results. During the study period, 150 patients underwent primary CAS, 75%
with embolic protection. Fifty-eight percent were symptomatic. One hundred
twenty-seven (85%) were treated for ASOD, and 23 (15%) had XRT. The 30-
day all-cause mortality rate was 1% for ASOD and 0% for XRT (P¼NS); over-
all survival at 3 years was equivalent. There was no significant difference in
major adverse event rates as defined by the Stenting and Angioplasty with
Protection in Patients at High Risk for Endarterectomy (SAPPHIRE) trial be-
tween the groups. The 3-year neurologic event-free rate was 85% for ASOD
and 87% for XRT (P¼NS). Late asymptomatic occlusions were seen only in
XRT patients. The 3-year freedom from restenosis rate was significantly
worse for the XRT group, at 20%, vs 74% for the ASOD group (P < .05). Like-
wise, the 3-year patency rate was also worse for the XRT group, at 91%, vs
100% for ASOD by Kaplan-Meier analysis (P < .05). No factor was predictive
of occlusion or stenosis by Cox proportional hazards analysis.
Conclusion. CAS for radiation arteritis has poor long-term anatomic outcome
and can present with late asymptomatic occlusions. These findings suggest
that these patients require closer postoperative surveillance and raise theEur J Vasc Endovasc Surg Vol 33, January 2007
130 Abstractsquestion of whether CAS is appropriate for carotid occlusive lesions caused
by radiation arteritis.
A randomized trial of T3-T4 versus T4 sympathectomy for isolated
axillary hyperhidrosis
M.A.S. Munia, N. Wolosker, P. Kauffman, J.R. de Campos and P. Puech-Le~ao
Introduction. Video-assisted thoracic sympathectomy (VATS) is oneminimally
invasive definitive treatment for axillary hyperhidrosis. Different techniques
exist for controlling axillary sudoresis, but they are temporary and have high
cost. This study was conducted to compare the initial results from sympathec-
tomy using two distinct levels for treating axillary sudoresis: T3-T4 vs T4.
Methods. Sixty-two patients with axillary hyperhidrosis were prospectively
randomized for denervation of T3-T4 or T4 alone. All patients were examinedEur J Vasc Endovasc Surg Vol 33, January 2007preoperatively and were followed-up at 1 and 6 months postoperatively.
Evaluated were the axillary hyperhidrosis treatment, the presence, location,
and severity of compensatory hyperhidrosis, and the quality of life.
Results. All the patients said that their axillary hyperhidrosis was success-
fully treated by the surgery after 6 months. There was no treatment failure.
Compensatory hyperhidrosis was present in 29 patients (90.6%) of the T3-
T4 group and in 17 T4 patients (56.7%) after 1 month. After 6 months, all
the T3-T4 patients presented some degree of compensatory hyperhidrosis
vs 13 T4 patients (43.3%). The severity of the compensatory hyperhidrosis
was also lower in the T4 patients (P < . 01). The quality of life was poor in
both groups before the surgery, and was equally improved in both groups
after 1 and 6 months of follow-up. There were no deaths or significant post-
operative complications nor a need for conversion to thoracotomy.
Conclusion. Both techniques are effective for treating axillary hyperhidrosis,
but the T4 group presented milder compensatory hyperhidrosis and had
a greater satisfaction rate.
